The researchers followed 17 patients over a one-year period, tracking their pain levels and improvement after treatment
These shots are given weekly or monthly, based on the patients needs and how theyre doing
Known benefits of BPC-157 include faster healing in multiple types of tissue, such as hepatic, vascular, and nervous, suggesting its potential to treat neurological and cardiovascular diseases
FDA adopted the same defined fragment in its 2026 review
BPC-157 upregulates VEGF, the vascular endothelial growth factor that directs the formation of new capillaries
The Canadian Peptide Research Society is one organization helping advance peptide science in Canada through: research collaboration education and training scientific conferences and knowledge sharing exploration of emerging clinical applications You can learn more about their work here: Current research efforts in Canada and internationally are focused on: developing peptide-based medications (e.g., metabolic and hormone therapies) understanding how peptides influence tissue repair and inflammation advancing drug discovery and personalized medicine However, in musculoskeletal medicine specifically: most research remains preclinical (animal and laboratory studies) high-quality human clinical trials are still limited What this means for patients: Peptide research is an active and evolving field, and Canada is contributing to its development